CSOP CSI STAR and CHINEXT 50 Index ETF (SGX: SCY) December 8, 2022

CSOP CSI STAR and CHINEXT 50 Index ETF (SGX: SCY)

With China beginning to relax its COVID-19 measures, is now the right time to start investing into China? What are some promising industries you should be looking into?

At the 20th National Congress of the Chinese Communist Party (CCP), President Xi reiterated that high quality development remains a top priority for China in order for it to achieve basic socialist modernisation by 2035.

In the congress, the CCP also highlighted that technological improvements, common prosperity and green development are crucial for China. The CCP also emphasised the need for China to continue to establish a globally competitive and open eco system of innovation to enhancing supply chain security and promote greater emphasis on self-reliance.

Technological innovation is the new growth engine of China for the following reasons:

Important GDP Drivers: New technologies (e.g., mobile internet, new energy) and emerging industries are becoming important forces that drive GDP growth in China.

Policy Support: Science and technology innovation is a key method for China’s economy to shift from high-speed growth to high-quality development, thus it has been a national strategy and the related sectors have received continuous policy support.

Huge Potential: Although the level of science and technology innovation and the proportion of research expenditure to GDP has been rising in recent years, it is still lower than those of developed countries in the 1990s, implying huge room for growth in the field of science and technology.

(Source: CSOP, UBS, Citi, Bloomberg)

Investors who are interested in the Chinese markets and want to start investing in an industry that has support and potential for growth can consider participating in the space of innovation and technology advancement in China.

Some notable indices for this industry include the CSOP CSI STAR and CHINEXT 50 Index ETF!

Here are some benefits of the CSOP CSI STAR and CHINEXT 50 Index ETF:

  • Comprehensive Exposure within the greatest Chinese companies with the highest growth potential listed in the Shanghai & Shenzhen Stock Exchanges.
  • Net profit growth of STAR companies and CHINEXT companies reached 59% and 43% respectively in 2020; the highest seen since 2010.
    In Q1 2021, the net profit of STAR and CHINEXT companies also further increased by 216% and 114% respectively.
  • Underlying index: CSI STAR & CHINEXT 50 Index
  • Transparent charges of management fees; which are currently at 0.89% per annum. (Maximum of 1.50% per annum of the Net Asset Value)

 

Overview

STAR Market CHINEXT Market
Classification “Hard technology” companies which are in line with National Strategies, represents Key Breakthroughs and have high Market Recognition. Growth focused companies with a generally smaller market capitalisation.
Supports the integration of traditional industries with new technologies, industries and business models.
Industries Only firms that meet certain scientific and technological criteria. Innovative enterprises in both traditional and new business segments. Comprises of F&B, Software, Semiconductors and Healthcare companies.
Listing Criteria Lower requirements for market capitalisation, revenue and earnings. Higher financial requirements and greater profit stability requirements

(Source: CSOP, UBS, Citi, Bloomberg)

If the above sounds like what you are looking for in your portfolio you can consider subscribing to them during the upcoming IOP!

Subscribe to the CSOP CSI STAR and CHINEXT 50 Index ETF during the Initial Offering Period (IOP) via POEMS 2.0

  • Using Google Chrome Browser – Login to your POEMS 2.0 account > Acct Mgt > Online Forms > IPO Subscription – Irrevocable Form
  • Select the IPO that you wish to subscribe to
  • Read and agree to the prospectus, terms and conditions before subscribing to the financial product
  • Application closes on 19 December 2022 (Monday), 5pm
  • Ensure sufficient cash is present in your POEMS 2.0 account to complete the application process (inclusive of subscription amount, commission, transfer fee and GST) by the settlement date on 19 December 2022 (Monday), 5pm

 

Join us at our webinar to learn more about this ETF

Date/Time Title Venue
13 Dec, Tue
03:00pm-04:00pm
CSOP CSI Star and ChiNext 50 Index ETF IOP

Adrian Chew | Vice President, Sales and Product Strategy (S.E.A) | CSOP Asset Management

Webinar
16 Dec, Frin
02:00pm-03:00pm
CSOP CSI Star and ChiNext 50 Index ETF IOP

Adrian Chew | Vice President, Sales and Product Strategy (S.E.A) | CSOP Asset Management

Webinar

IOP Subscription Detail

Subscription Period: 8 December 2022, 9am to 19 December 2022, 5pm
Listing Date: 30 December 2022
Subscription price: SGD 1.00 per unit
Minimum Quantity: Minimum of 1,000 units
1,000 units incremental subscription amount
Commission Fees: 0.08%
Transfer Fees:

SGD 10.00 (Subject to GST) for Cash Management Account

Other Phillip Investment Account Types will not be subjected to the transfer fee charge

Settlement Currency: SGD
Trading Currency:

Secondary Market Trading: SGD

IOP application will be for the SGD units

Allotment: Full allotment

 

CSOP CSI STAR and CHINEXT 50 Index ETF

Key Information

Instrument Type: Exchange Traded Fund “ETF”
Tracked Index: CSI STAR & CHINEXT 50 Index
Exchange Listing: SGX-ST – Main Board
 Classification: Excluded Investment Product (EIP)*
Trading Currency:

Primary Market Creation/Redemption: RMB, SGD

Secondary Market Trading: SGD

Board Lot Size: 1 Unit
Dividend Distribution Frequency: NIL
Management Fee and Total Expense Ratio: Currently 0.89% per annum of the Net Asset Value. Maximum of 1.50% per annum of the Net Asset Value
Manager: CSOP ASSET MANAGEMENT PTE. LTD.

*Please refer to the Prospectus for more information.

 

Benchmark Index Information

Key Attributes of the Index CSI STAR & CHINEXT 50 Index
Index Constituents Representation of the performance of 50 securities of listed companies involves emerging industries from SSE STAR market and SZSE ChiNext market as constituents
Number of Constituents* 50
Geographical Region* China
Top 5 Holdings in the Index*
  • Contemporary Amperex Technology Co., Limited. (8.231%)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (8.205%)
  • Sungrow Power Supply Co Ltd (7.076%)
  • Shenzhen Inovance Technology Co Ltd (6.399%)
  • Eve Energy Co Ltd (4.891%)

 

Join us at our webinar to learn more about this ETF

Date/Time Title Venue
13 Dec, Tue
03:00pm-04:00pm
CSOP CSI Star and ChiNext 50 Index ETF IOP

Adrian Chew | Vice President, Sales and Product Strategy (S.E.A) | CSOP Asset Management

Webinar
16 Dec, Frin
02:00pm-03:00pm
CSOP CSI Star and ChiNext 50 Index ETF IOP

Adrian Chew | Vice President, Sales and Product Strategy (S.E.A) | CSOP Asset Management

Webinar

Terms and Conditions

  • The subscription period for this ETF is from 8 December 2022, 9am to 19 December 2022, 5pm
  • The online subscription will close on 19 December 2022, 5pm. No new application, amendment, or withdrawal is allowed after this deadline.
  • The additional transfer fee charge of SGD 10 (Subject to GST) per application.
  • Six types of accounts namely Cash Plus, Cash Management (KC), Prepaid (CC), Custodian (C), Margin (M) and Share Financing (V) accounts are allowed to subscribe for this ETF.
  • Cash Trading Accounts (T) is are not eligible to participate in this subscription.
  • Only one application is allowed per account.
  • Each ETF unit priced at SGD 1 and the minimum order quantity is 1,000 units, at incremental order size of 1,000 units.
  • 0.08% (Subject to GST) for all account types
  • The total amount payable is denominated in SGD. Settlement currency will be in SGD.
  • Sufficient funds (transfer fee and GST) must be in the client’s trading account by 19 December 2022, 5pm
  • Application will be rejected if the account does not have/ reflect sufficient funds after 19 December 2022, 5pm.
  • ETF units will be credited to the clients’ CDP or clients’ sub-account with Phillip Securities Pte Ltd by 30 December 2022.
  • Clients will receive the full allotment of the number of ETF units that they subscribe to.
  • Clients can start trading the ETF units when the ETF is listed on SGX on 30 December 2022.

Investments are subject to investment risks including the possible loss of the principal amount invested. You should read the ETFs’ prospectus and the accompanying product highlights sheets for key features and key risks and seek advice from a financial adviser (“FA”) or you should assess and consider whether the ETFs are suitable for you before proceeding to invest in the ETFs. Listing on SGX does not guarantee a liquid market for the units of the ETFs, which may be traded at prices above or below its net assets value or may be suspended or delisted. Unlike unlisted unit trusts, investors cannot create/subscribe or redeem ETF units directly with the fund manager of the ETFs. Please refer to the Prospectus of the ETFs for more details.

Disclaimer

This material and the information herein is provided for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in the product (“REITs ETF”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. The information is subject to change at any time without notice. The value of the units and the income accruing to the units may fall or rise. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for disclosure of key features, key risks and other important information of the REITs ETF (which is available on websites of the issuers) and obtain advice from a financial adviser (“FA”) before making a commitment to invest in REITs ETF. In the event that you choose not to obtain advice from a FA, you should assess whether the REITs ETF is suitable for you before proceeding to invest.

The REITs ETF is not like a typical unit trust as it is intended for the units of the REITs ETF (the “Units”) to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its net asset value (“NAV”) or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Please refer to the Prospectus for more details.

Investments are subject to investment risks including the possible loss of the principal amount invested, and are not obligations of, deposits in, guaranteed or insured by Phillip Securities Pte Ltd (“PSPL”) or any of its subsidiaries, associates and affiliates. Past performance is not necessarily indicative of the future or likely performance of the REITs ETF. There can be no assurance that investment objectives will be achieved.

Any regular dividend distributions, either out of income and/or capital, are not guaranteed and subject to the fund manager’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the NAV of the ETF. Upon launch of the ETF, please refer to the fund manager’s website for more information in relation to the dividend distributions.

The information does not constitute and should not be used as a substitute for tax, legal or investment advice.

This information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PSPL to any registration or licensing requirement in such jurisdiction or country. The REITs ETF is not offered to U.S. Persons.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com